LOUISVILLE, Colo., Dec. 1, 2023 /PRNewswire/ — The initial findings of Colibri Heart Valve’s multicenter high-risk TAVR EU pilot study were presented at PCR London Valves November 20th, 2023. The study was conducted by CERC (Centre Européen de Recherche Cardiovasculaire) as acting CRO…
Related Articles
News
Pain Reprocessing Therapy Reduces Chronic Back Pain for Years, Study Finds
March 16, 2026
UCBN
News, Syndication
Comments Off on Pain Reprocessing Therapy Reduces Chronic Back Pain for Years, Study Finds
One in five people in the United States experiences chronic pain. Despite its prevalence, safe and effective treatments are lacking. Yet evidence demonstrates that a psychological intervention can heal pain – even five years after […]
News
Weekly Policy Blog: CBSA Releases 2022 Policy + Advocacy Report
January 9, 2023
UCBN
News
Comments Off on Weekly Policy Blog: CBSA Releases 2022 Policy + Advocacy Report
CBSA leads Policy + Advocacy to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in our ecosystem and the patients they […]
News
From Health to Wealth: COSI Agency’s Comprehensive Suite of Protection Plans Sets Industry Standards
April 8, 2024
UCBN
News, Syndication
Comments Off on From Health to Wealth: COSI Agency’s Comprehensive Suite of Protection Plans Sets Industry Standards
COLORADO SPRINGS, Colo., April 8, 2024 /PRNewswire/ — Elevating the standard of insurance coverage in the industry, COSI Agency proudly presents its comprehensive suite of protection plans tailored to meet the unique needs of clients […]
